Metabolomic and Proteomic Consequences of siRNA Therapies Targeting ANGPTL3 and APOC3 in Patients with Mixed Hyperlipidemia

Project Details

StatusNot started
Effective start/end date1/02/261/02/29

Funding

  • Arrowhead Australia Pty Ltd